|
인쇄하기
취소
|
KFDA to draft approval of protocol on drug
Published: 2002-11-08 06:59:00
Updated: 2002-11-08 06:59:00
The approval for revision of a clinical trial protocol on drug will be simplified and new drugs for clinical trial purpose may be administered to patients to a terminal-phase cancer and AIDS prior to market authorization, the Korea Food and Drug Administration (KFDA) said recently.
In parallel with the promulgation of the revised enforcement regulations of the Korea Pharmaceutical Affairs La...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.